90-18-6
90-18-6 结构式
基本信息
六羟黄酮/栎草亭
槲皮万寿菊素栎草亭
栎草亭,槲皮万寿菊素
3,3',4',5,6,7-六羟基黄酮
QUERCETAGETIN
QUERCETAGENIN
6-Hydroxyquercetin
6,7,4'-Quercetagetin
QUEBRACHITOL, (-)-(RG)
Quercetagetin 7-glucoside
3,5,6,7,3',4'-HEXAHYDROXYFLAVONE
3,3',4',5,6,7-HEXAHYDROXYFLAVONE
QuercetagitrinQuercetagetin 7-glucoside
物理化学性质
常见问题列表
|
PIM1 0.34 μM (IC 50 ) |
PIM2 3.45 μM (IC 50 ) |
RSK2 2.82 μM (IC 50 ) |
PKA 21.2 μM (IC 50 ) |
Quercetagetin also inhibits PIM2, PKA, and RSK2 with IC
50
s of 3.45, 21.2, and 2.82 µM, respectively.
Quercetagetin (0.1, 1, 10, and 100 μM, 72 hours) inhibits growth of RWPE2 prostate cancer cells with average ED
50
is 3.8 μM.
Cell Viability Assay
| Cell Line: | RWPE2 prostate cancer cells |
| Concentration: | 0.1, 1, 10, and 100 μM |
| Incubation Time: | 72 hours |
| Result: | Inhibited growth of RWPE2 prostate cancer cells with average ED 50 is 3.8 μM. |
Quercetagetin significantly inhibits UVB-induced skin cancer development. Topical application of 4 or 20 nmol of Quercetagetin to mouse skin reduces tumor incidence by 32.0% and 46.7%, respectively.
| Animal Model: | SKH-1 hairless mice model |
| Dosage: | 4 or 20 nmol |
| Administration: | Topical application; 28 weeks |
| Result: | Inhibited UVB-induced skin tumorigenesis in SKH-1 hairless mice models. Delayed the development of tumors and reduced tumor volumes in an SKH-1 hairless mice model. |